Tag: 23andMe

January 25, 2018

What Is Genomics?

Genomics, the study of genetic information within all living beings provides an insight into a patient's genetics which opens the...
December 28, 2017

Genetics Outlook 2018: Can the Potential Show Up in the Market?

The Investing News Network takes a closer look at the genetics market in 2017 and what 2018 may have in...
July 20, 2017

Rennova Health Launches AMSG, a Machine Learning AI in the Genetic Testing Market

Rennova decided to spin off its genetic division and create a brand new, publicly traded company, INN interviews the CEO...
October 3, 2016

FDA Intervention in DTC Genetic Testing: A Timeline

There is still a great deal of debate over the FDA’s role in regulating medical devices and pharmaceutical products. So...
June 16, 2016

Illumina Announces Initial Customer Orders for the Global Screening Array

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has signed deals with 12 customers for its new Infinium®...
May 29, 2016

Human Genome Sciences Stock May Benefit from Big Pharma Breakthroughs

Big pharma is achieving major breakthroughs backed by genetics research, and ultimately more than one human genome sciences stock may...
December 6, 2015

Top Trends for Genomics Stocks in 2016

The democratization of genetic sequencing and debate over the ethical implications of Crispr/Cas9 promise to be two of the top...